These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6721515)

  • 1. [Breast cancer--topics from basic research].
    Matsumoto K; Kuroda H; Takeyama M
    Gan To Kagaku Ryoho; 1984 May; 11(5):974-80. PubMed ID: 6721515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone receptors and Japanese breast cancer.
    Matsumoto K; Kitamura Y; Sugano H
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone receptor modulation in xenotransplanted endocrine related human breast cancer.
    Michel RT; Vering A; Fortmeyer HP; Stegmüller M
    Strahlenther Onkol; 1989 Jul; 165(7):497-8. PubMed ID: 2749477
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone therapy--recent advances].
    Matsumoto K; Noguchi S
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2816-23. PubMed ID: 2959202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Internal endocrine therapy of breast cancer].
    Yoshida M; Miura S
    Gan To Kagaku Ryoho; 1984 May; 11(5):989-98. PubMed ID: 6372698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droloxifene--a novel antiestrogen in endocrine dependent human tumors xenotransplanted into nude mice.
    Stelzer P; Staab HJ; Kömpf J
    Strahlenther Onkol; 1989 Jul; 165(7):559-60. PubMed ID: 2749496
    [No Abstract]   [Full Text] [Related]  

  • 12. [Developments in endocrine therapy for breast cancer].
    Matsui A; Ikeda T; Jinno H; Tajima G; Hohjou T; Tokura H; Mitsui Y; Asaga S; Muto T; Kitajima M
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1138-45. PubMed ID: 12145993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid hormone receptors in the management of human breast cancer.
    Knight WA; Osborne CK; Yochmowitz MG; McGuire WL
    Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progesterone receptors in breast cancer].
    Vitola GIa; Zeĭkate GA; Grabovska IK
    Vopr Onkol; 1987; 33(9):35-8. PubMed ID: 3660754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
    Jovanović-Mićić D; Beleslin DB; Nikolić SS
    Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of hormone therapy in metastasizing breast cancer].
    Samonigg H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine therapy of breast and prostate cancer.
    Manni A
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation between estrogen and progesterone receptors and response to hormone therapy].
    Leclercq G; Paridaens R; Heuson JC
    Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.